Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2

Ann Clin Transl Neurol. 2021 Oct;8(10):2000-2003. doi: 10.1002/acn3.51447. Epub 2021 Sep 4.

Abstract

Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease, and there are some data that link this event with various vaccinations. We report a young female admitted to the hospital with headache, fever, back pain, nausea, vomiting, and urinary retention. Two weeks prior, she received the first dose of SARS-CoV-2 mRNA vaccine. Brain and spinal cord magnetic resonance imaging (MRI) showed distinctive for ADEM widespread demyelinating lesions. The patient was successfully treated with methylprednisolone.

Publication types

  • Case Reports

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Brain / diagnostic imaging
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / adverse effects*
  • Encephalomyelitis, Acute Disseminated / chemically induced*
  • Encephalomyelitis, Acute Disseminated / diagnostic imaging*
  • Female
  • Humans
  • Young Adult

Substances

  • COVID-19 Vaccines
  • 2019-nCoV Vaccine mRNA-1273